Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amado J Zurita

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 23, 2003
Mapping tumor vascular diversity by screening phage display librariesAmado J Zurita, Wadih Arap, Renata Pasqualini
Molecular Diagnosis & Therapy|April 21, 2012
Circulating biomarkers of response to sunitinib in gastroenteropancreatic neuroendocrine tumors: current data and clinical outlookJoaquin Mateo, John V Heymach, Amado J Zurita
Current Oncology Reports|March 22, 2012
Circulating biomarkers in advanced renal cell carcinoma: clinical applicationsMaria Hernandez-Yanez, John V Heymach, Amado J Zurita
Future Medicinal Chemistry|December 16, 2011
Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancerGary E Gallick, Paul G Corn, Amado J Zurita, et al.
Oncotarget|February 9, 2017
Plasma cytokine and angiogenic factors associated with prognosis and therapeutic response to sunitinib vs everolimus in advanced non-clear cell renal cell carcinomaPavlos Msaouel, Amado J Zurita, Shixia Huang, et al.
Clinical Nuclear Medicine|September 21, 2020
18F-Fluciclovine Uptake in a UreteroceleRyan Bitar, Janio Szklaruk, Lucia Martiniova, et al.
Cancer|April 30, 2009
Circulating biomarkers for vascular endothelial growth factor inhibitors in renal cell carcinomaAmado J Zurita, Eric Jonasch, Hua-Kang Wu, et al.
Cancer Research|January 28, 2004
Combinatorial screenings in patients: the interleukin-11 receptor alpha as a candidate target in the progression of human prostate cancerAmado J Zurita, Patricia Troncoso, Marina Cardó-Vila, et al.
Chemistry & Biology|August 25, 2004
Design and validation of a bifunctional ligand display system for receptor targetingLimor Chen, Amado J Zurita, Peter U Ardelt, et al.
Neuro-Oncology|September 12, 2012
Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotypeYuji Piao, Ji Liang, Lindsay Holmes, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 23, 2003
Mapping tumor vascular diversity by screening phage display librariesAmado J Zurita, Wadih Arap, Renata Pasqualini
Molecular Diagnosis & Therapy|April 21, 2012
Circulating biomarkers of response to sunitinib in gastroenteropancreatic neuroendocrine tumors: current data and clinical outlookJoaquin Mateo, John V Heymach, Amado J Zurita
Current Oncology Reports|March 22, 2012
Circulating biomarkers in advanced renal cell carcinoma: clinical applicationsMaria Hernandez-Yanez, John V Heymach, Amado J Zurita
Future Medicinal Chemistry|December 16, 2011
Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancerGary E Gallick, Paul G Corn, Amado J Zurita, et al.
Oncotarget|February 9, 2017
Plasma cytokine and angiogenic factors associated with prognosis and therapeutic response to sunitinib vs everolimus in advanced non-clear cell renal cell carcinomaPavlos Msaouel, Amado J Zurita, Shixia Huang, et al.
Clinical Nuclear Medicine|September 21, 2020
18F-Fluciclovine Uptake in a UreteroceleRyan Bitar, Janio Szklaruk, Lucia Martiniova, et al.
Cancer|April 30, 2009
Circulating biomarkers for vascular endothelial growth factor inhibitors in renal cell carcinomaAmado J Zurita, Eric Jonasch, Hua-Kang Wu, et al.
Cancer Research|January 28, 2004
Combinatorial screenings in patients: the interleukin-11 receptor alpha as a candidate target in the progression of human prostate cancerAmado J Zurita, Patricia Troncoso, Marina Cardó-Vila, et al.
Chemistry & Biology|August 25, 2004
Design and validation of a bifunctional ligand display system for receptor targetingLimor Chen, Amado J Zurita, Peter U Ardelt, et al.
Neuro-Oncology|September 12, 2012
Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotypeYuji Piao, Ji Liang, Lindsay Holmes, et al.
Pageof 8